Serum migration-inhibitory activity in patients with acute leukemia and early leukemic lymphosarcoma.
D000208:Acute Disease; D002465:Cell Movement; D005591:Chemical Fractionation; D003470:Culture Media; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D007961:Leukocyte Migration-Inhibitory Factors / Q000097:blood*; D007962:Leukocytes / Q000276:immunology; D008222:Lymphokines / Q000097:blood*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D012075:Remission, Spontaneous; D013997:Time Factors
D003470:Culture Media; D007961:Leukocyte Migration-Inhibitory Factors; D008222:Lymphokines